We are pleased to invite you to attend the GAPP JA Final Dissemination Conference, which will take place as a hybrid event, on the 20 th & 21 st January 2022, with the host location being Thessaloniki, Greece.
GAPP (facilitatinG the Authorisation of Preparation Process for blood, tissues and cells) is a Joint Action (JA) co-funded by the European Commission under the EU Health Programme, aiming to facilitate the development of common and optimal approach to access and authorize new preparation processes in Blood and Tissue Establishments. You can find more details in the webpage https://www.gapp-ja.eu/ and in our two-minute video.
The GAPP JA Final Dissemination Conference aims to bring together a diverse audience and key high-level representatives from EU Institutions, partners, experts and scientific associations, as well as donors and patients’ associations to stimulate multi-stakeholder dialogue and views, and promote optimal use of SoHOs and a uniform approach across the EU.
Day one of the event comprises of the presentations of Work-Package (WP) leaders along with an overview on the work carried out in each WP during the course of the Action.
Day two, is dedicated to interactive sessions and discussions on how to effectively bridge the gap between science and effective policies.
The Preliminary Agenda is available online and details on the conference can be found in the link GAPP DISSEMINATION CONFERENCE 2022.
Please do not hesitate to share this invitation among interested colleagues or stakeholders, and /or share on your organisation’s intranet or news-section. The event is free of charge and is now open for registration.
To allow us to best prepare the online platform, we would appreciate if you could state your intention to participate virtually by registering in the registration link provided by December 20th .
Should you have any questions, feel free to contact the GAPP Dissemination & Communication team conference@gapp-ja.eu
With our kindest regards,
Massimo Cardillo Scientific Coordinator, CNT Director
Vincenzo De Angelis Scientific coordinator CNS Director
